|
1
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res 14 (10A). 1902–1910. 2004.
View Article : Google Scholar
|
|
3
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai EC: Micro RNAs are complementary to 3′
UTR sequence motifs that mediate negative post-transcriptional
regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Smaele E, Ferretti E and Gulino A:
MicroRNAs as biomarkers for CNS cancer and other disorders. Brain
Res. 1338:100–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schratt GM, Tuebing F, Nigh EA, Kane CG,
Sabatini ME, Kiebler M and Greenberg ME: A brain-specific microRNA
regulates dendritic spine development. Nature. 439:283–289. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smirnova L, Gräfe A, Seiler A, Schumacher
S, Nitsch R and Wulczyn FG: Regulation of miRNA expression during
neural cell specification. Eur J Neurosci. 21:1469–1477. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dogini DB, Ribeiro PA, Rocha C, Pereira TC
and Lopes-Cendes I: MicroRNA expression profile in murine central
nervous system development. J Mol Neurosci. 35:331–337. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hansen T, Olsen L, Lindow M, Jakobsen KD,
Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I,
et al: Brain expressed microRNAs implicated in schizophrenia
etiology. PLoS One. 2:e8732007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beveridge NJ, Tooney PA, Carroll AP,
Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I and Cairns MJ:
Dysregulation of miRNA 181b in the temporal cortex in
schizophrenia. Hum Mol Genet. 17:1156–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cammaerts S, Strazisar M, Smets B,
Weckhuysen S, Nordin A, De Jonghe P, Adolfsson R, De Rijk P and Del
Favero J: Schizophrenia-Associated MIR204 Regulates Noncoding RNAs
and Affects Neurotransmitter and Ion Channel Gene Sets. PLoS One.
10:e01444282015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Fan M, Wang Q, He G, Fu Y, Li H
and Yu S: Polymorphisms in MicroRNA Genes And Genes Involving in
NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese
Han Population. Sci Rep. 5:129842015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gumerov V and Hegyi H: MicroRNA-derived
network analysis of differentially methylated genes in
schizophrenia, implicating GABA receptor B1 [GABBR1] and protein
kinase B [AKT1]. Biol Direct. 10:592015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Preti A and Wilson DR: Schizophrenia,
cancer and obstetric complications in an evolutionary
perspective-an empirically based hypothesis. Psychiatry Investig.
8:77–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Catts VS, Catts SV, McGrath JJ, Féron F,
McLean D, Coulson EJ and Lutze-Mann LH: Apoptosis and
schizophrenia: A pilot study based on dermal fibroblast cell lines.
Schizophr Res. 84:20–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Glantz LA, Gilmore JH, Lieberman JA and
Jarskog LF: Apoptotic mechanisms and the synaptic pathology of
schizophrenia. Schizophr Res. 81:47–63. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni X, Trakalo J, Valente J, Azevedo MH,
Pato MT, Pato CN and Kennedy JL: Human p53 tumor suppressor gene
(TP53) and schizophrenia: Case-control and family studies. Neurosci
Lett. 388:173–178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Catts VS, Catts SV, O'Toole BI and Frost
AD: Cancer incidence in patients with schizophrenia and their
first-degree relatives - a meta-analysis. Acta Psychiatr Scand.
117:323–336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Odegaard F: Mortality in Norwegian mental
hospitals from 1916 to 1933. Acta Psychiatr Scand. 11:323–356.
1936. View Article : Google Scholar
|
|
22
|
Commissioners in Lunacy for England and
Wales, . Annual Report. HMSO; London: 1909
|
|
23
|
Mortensen PB: The incidence of cancer in
schizophrenic patients. J Epidemiol Community Health. 43:43–47.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lawrence D, Jablensky AV, Holman CD and
Pinder TJ: Mortality in Western Australian psychiatric patients.
Soc Psychiatry Psychiatr Epidemiol. 35:341–347. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barak Y, Achiron A, Mandel M, Mirecki I
and Aizenberg D: Reduced cancer incidence among patients with
schizophrenia. Cancer. 104:2817–2821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leucht S, Burkard T, Henderson J, Maj M
and Sartorius N: Physical illness and schizophrenia: A review of
the literature. Acta Psychiatr Scand. 116:317–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chou FHC, Tsai KY, Su CY and Lee CC: The
incidence and relative risk factors for developing cancer among
patients with schizophrenia: A nine-year follow-up study. Schizophr
Res. 129:97–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crespi B: Autism and cancer risk. Autism
Res. 4:302–310. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin GM, Chen YJ, Kuo DJ, Jaiteh LE, Wu YC,
Lo TS and Li YH: Cancer incidence in patients with schizophrenia or
bipolar disorder: A nationwide population-based study in Taiwan,
1997–2009. Schizophr Bull. 39:407–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao
L, Cai H, Li P, Cao Q, Ju X, et al: miR-152 controls migration and
invasive potential by targeting TGFα in prostate cancer cell lines.
Prostate. 73:1082–1089. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qu Y, Li WC, Hellem MR, Rostad K, Popa M,
McCormack E, Oyan AM, Kalland KH and Ke XS: MiR-182 and miR-203
induce mesenchymal to epithelial transition and self-sufficiency of
growth signals via repressing SNAI2 in prostate cells. Int J
Cancer. 133:544–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan X, Chen X, Deng W, Zhong G, Cai Q and
Lin T: Up-regulated microRNA-143 in cancer stem cells
differentiation promotes prostate cancer cells metastasis by
modulating FNDC3B expression. BMC Cancer. 13:612013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Christensen LL, Tobiasen H, Holm A,
Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH,
Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, et al: COLOFOL
steering group: MiRNA-362-3p induces cell cycle arrest through
targeting of E2F1, USF2 and PTPN1 and is associated with recurrence
of colorectal cancer. Int J Cancer. 133:67–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY
and Juo SH: Computational analysis of mRNA expression profiles
identifies microRNA-29a/c as predictor of colorectal cancer early
recurrence. PLoS One. 7:e315872012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan
FK, Sung JJ and Yu J: MicroRNA-218 inhibits cell cycle progression
and promotes apoptosis in colon cancer by downregulating BMI1
polycomb ring finger oncogene. Mol Med. 18:1491–1498.
2013.PubMed/NCBI
|
|
36
|
Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu
Z, Hu G and Yang Q: MicroRNA-30a suppresses breast tumor growth and
metastasis by targeting metadherin. Oncogene. 33:3119–3128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cui W, Zhang S, Shan C, Zhou L and Zhou Z:
microRNA-133a regulates the cell cycle and proliferation of breast
cancer cells by targeting epidermal growth factor receptor through
the EGFR/Akt signaling pathway. FEBS J. 280:3962–3974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hwang MS, Yu N, Stinson SY, Yue P, Newman
RJ, Allan BB and Dornan D: miR-221/222 targets adiponectin receptor
1 to promote the epithelial-to-mesenchymal transition in breast
cancer. PLoS One. 8:e665022013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anaya-Ruiz M, Cebada J, Delgado-López G,
Sánchez-Vázquez ML and Pérez-Santos JL: miR-153 silencing induces
apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J
Cancer Prev. 14:2983–2986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Arora H, Qureshi R and Park WY: miR-506
regulates epithelial mesenchymal transition in breast cancer cell
lines. PLoS One. 8:e642732013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schliekelman MJ, Gibbons DL, Faca VM,
Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn
YH, et al: Targets of the tumor suppressor miR-200 in regulation of
the epithelial-mesenchymal transition in cancer. Cancer Res.
71:7670–7682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Johansson J, Berg T, Kurzejamska E, Pang
MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, et
al: MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from
growth inhibition to epithelial-mesenchymal transition, invasion
and metastasis in breast cancer. Oncogene. 32:5614–5624. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gebeshuber CA, Zatloukal K and Martinez J:
miR-29a suppresses tristetraprolin, which is a regulator of
epithelial polarity and metastasis. EMBO Rep. 10:400–405. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
You J, Li Y, Fang N, Liu B, Zu L, Chang R,
Li X and Zhou Q: MiR-132 suppresses the migration and invasion of
lung cancer cells via targeting the EMT regulator ZEB2. PLoS One.
9:e918272014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao X, Yeo G, Muotri AR, Kuwabara T and
Gage FH: Noncoding RNAs in the mammalian central nervous system.
Annu Rev Neurosci. 29:77–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vo N, Klein ME, Varlamova O, Keller DM,
Yamamoto T, Goodman RH and Impey S: A cAMP-response element binding
protein-induced microRNA regulates neuronal morphogenesis. Proc
Natl Acad Sci USA. 102:16426–16431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hunsberger JG, Austin DR, Chen G and Manji
HK: MicroRNAs in mental health: From biological underpinnings to
potential therapies. Neuromolecular Med. 11:173–182. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Perkins DO, Jeffries CD, Jarskog LF,
Thomson JM, Woods K, Newman MA, Parker JS, Jin J and Hammond SM:
microRNA expression in the prefrontal cortex of individuals with
schizophrenia and schizoaffective disorder. Genome Biol. 8:R272007.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu Y, Li F, Zhang B, Zhang K, Zhang F,
Huang X, Sun N, Ren Y, Sui M and Liu P: MicroRNAs and target site
screening reveals a pre-microRNA-30e variant associated with
schizophrenia. Schizophr Res. 119:219–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lewis DA and Lieberman JA: Catching up on
schizophrenia: Natural history and neurobiology. Neuron.
28:325–334. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rizos E, Siafakas N, Katsantoni E, Skourti
E, Salpeas V, Rizos I, Tsoporis JN, Kastania A, Filippopoulou A,
Xiros N, et al: Let-7, mir-98 and mir-183 as biomarkers for cancer
and schizophrenia [corrected]. PLoS One. 10:e01235222015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jarskog LF, Glantz LA, Gilmore JH and
Lieberman JA: Apoptotic mechanisms in the pathophysiology of
schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry.
29:846–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shorter KR and Miller BH: Epigenetic
mechanisms in schizophrenia. Prog Biophys Mol Biol. 118:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rizos E, Siafakas N, Koumarianou A,
Katsantoni E, Filippopoulou A, Ntounas P, Touloumis Ch, Kastania A
and Zoumpourlis V: miR-183 as a molecular and protective biomarker
for cancer in schizophrenic subjects. Oncol Rep. 28:2200–2204.
2012.PubMed/NCBI
|
|
57
|
Fu LL, Wen X, Bao JK and Liu B:
MicroRNA-modulated autophagic signaling networks in cancer. Int J
Biochem Cell Biol. 44:733–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li ZY, Yang Y, Ming M, Liu B and Li ZY:
Mitochondrial ROS generation for regulation of autophagic pathways
in cancer. Biochem Biophys Res Commun. 414:5–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Abraham D, Jackson N, Gundara JS, Zhao J,
Gill AJ, Delbridge L, Robinson BG and Sidhu SB: MicroRNA profiling
of sporadic and hereditary medullary thyroid cancer identifies
predictors of nodal metastasis, prognosis, and potential
therapeutic targets. Clin Cancer Res. 17:4772–4781. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang G, Mao W and Zheng S: MicroRNA-183
regulates Ezrin expression in lung cancer cells. FEBS Lett.
582:3663–3668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tabarés-Seisdedos R and Rubenstein JL:
Chromosome 8p as a potential hub for developmental neuropsychiatric
disorders: Implications for schizophrenia, autism and cancer. Mol
Psychiatry. 14:563–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Docherty AR, Bigdeli TB, Edwards AC,
Bacanu S, Lee D, Neale MC, Wormley BK, Walsh D, O'Neill FA, Riley
BP, et al: Genome-wide gene pathway analysis of psychotic illness
symptom dimensions based on a new schizophrenia-specific model of
the OPCRIT. Schizophr Res. 164:181–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fanous AH and Kendler KS: Genetic
heterogeneity, modifier genes, and quantitative phenotypes in
psychiatric illness: Searching for a framework. Mol Psychiatry.
10:6–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ruderfer DM, Fanous AH, Ripke S, McQuillin
A, Amdur RL, Gejman PV, O'Donovan MC, Andreassen OA, Djurovic S,
Hultman CM, et al: Schizophrenia Working Group of Psychiatric
Genomics Consortium; Bipolar Disorder Working Group of Psychiatric
Genomics Consortium; Cross-Disorder Working Group of Psychiatric
Genomics Consortium: Polygenic dissection of diagnosis and clinical
dimensions of bipolar disorder and schizophrenia. Mol Psychiatry.
19:1017–1024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang J, Wang Y, Yang J and Huang Y:
microRNAs as novel biomarkers of schizophrenia (Review). Exp Ther
Med. 8:1671–1676. 2014.PubMed/NCBI
|
|
67
|
Xu Y, Yue W, Yao Shugart Y, Li S, Cai L,
Li Q, Cheng Z, Wang G, Zhou Z, Jin C, et al: Exploring
Transcription Factors-microRNAs Co-regulation Networks in
Schizophrenia. Schizophr Bull. 42:1037–1045. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Shi W, Du J, Qi Y, Liang G, Wang T, Li S,
Xie S, Zeshan B and Xiao Z: Aberrant expression of serum miRNAs in
schizophrenia. J Psychiatr Res. 46:198–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cui DH, Jiang KD, Jiang SD, Xu YF and Yao
H: The tumor suppressor adenomatous polyposis coli gene is
associated with susceptibility to schizophrenia. Mol Psychiatry.
10:669–677. 2005. View Article : Google Scholar : PubMed/NCBI
|
